Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2025)
Revolution Medicines' quarterly Amortizatization of Intangibles came in at $99000.0 in Q4 2025, up 105.79% year-on-year from $48108.2 in Q4 2024, and down 67.0% quarter-over-quarter from $300000.0 in Q3 2025.
Revolution Medicines has reported Amortizatization of Intangibles for 7 years, with the latest figure at $99000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 105.79% year-over-year to $99000.0; the trailing twelve-month figure through Mar 2026 stood at $699000.0 (up 182.82% YoY), and the FY2025 full-year result was $900000.0, down 18.18% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $99000.0, down from $300000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $21.4 million in Q4 2023, with the low at -$2.4 million in Q4 2022.
- Average Amortizatization of Intangibles over 5 years is $990700.0, with a median of $300000.0 recorded in 2021.
- Year-over-year, Amortizatization of Intangibles slumped 316.0% in 2022 and surged 1005.46% in 2023.
- Tracing RVMD's Amortizatization of Intangibles over 5 years: stood at -$1.1 million in 2021, then slumped by 114.71% to -$2.4 million in 2022, then surged by 1005.46% to $21.4 million in 2023, then tumbled by 107.99% to -$1.7 million in 2024, then jumped by 105.79% to $99000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $99000.0 (Q4 2025), $300000.0 (Q3 2025), and $300000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,000.00 |
| Dec 31, 2025 | 99,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 267,000.00 |
| Mar 31, 2025 | 267,000.00 |
| Dec 31, 2024 | -1.71 Mn |
| Dec 31, 2024 | -1.71 Mn |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Dec 31, 2023 | 21.41 Mn |
| Dec 31, 2023 | 21.41 Mn |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | -2.36 Mn |
| Dec 31, 2022 | -2.36 Mn |
| Sep 30, 2022 | 300,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | -648,000.00 |
| Mar 31, 2022 | -648,000.00 |
| Dec 31, 2021 | -1.10 Mn |
| Dec 31, 2021 | -1.10 Mn |
| Sep 30, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | -1.01 Mn |
| Dec 31, 2020 | -1.01 Mn |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 105,000.00 |
| Mar 31, 2020 | 105,000.00 |
| Dec 31, 2019 | 267,000.00 |
| Dec 31, 2019 | 267,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 300,000.00 |
| Mar 31, 2019 | 267,000.00 |
| Mar 31, 2019 | 267,000.00 |